Form 4 for RMD ResMed|
Accepted 2023-08-18 00:00:00 ET · period of report 2023-08-17 · accession 0001127602-23-022925 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-18 | 2023-08-17 | RMD | Farrell Michael J. | CEO | A - Grant | $0.00 | +12.4K | 449.4K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-08-17 | A | A | 12,430 | $0.00 | 449,360 | D | — | — |